Why women reject breast cancer preventing drug – new study
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models | npj Breast Cancer
Tamoxifen: what you should and shouldn't avoid - OWise UK
.jpg "Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis")
Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis
Why So Many of Us Quit Taking Tamoxifen | FORCE: Facing our Risk of Cancer Empowered Blog
mamo.cz - Tamoxifen class drugs reduce breast cancer rates by more than a third in women at high risk
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial - The Lancet
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials - The Lancet
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial | Journal of Clinical Oncology
Tamoxifen to prevent breast cancer? - Website for Liz O'Riordan
Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering | Scientific Reports
Practical Steps to Prevent Breast Cancer: Day 9 - If High Risk: Consider Risk-Reducing Medications | Public Health Sciences Division | Washington University in St. Louis
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic | British Journal of Cancer
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis - The Lancet Oncology
The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor–Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women - Value in Health Regional Issues
Tamoxifen Helps Prevent Breast Cancer, but Women Reluctant to Take It
Medicina | Free Full-Text | Pharmacogenomics, CYP2D6, and Tamoxifen: A Survey of the Reasons Sustaining European Clinical Practice Paradigms
Making Choices
CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation: Molecular Therapy - Oncolytics
Tamoxifen Accelerates Endothelial Healing by Targeting ERα in Smooth Muscle Cells | Circulation Research
Why I'm taking tamoxifen to avoid breast cancer | MD Anderson Cancer Center
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology
Tamoxifen Not Associated With Higher Risk for Cataracts in Women With DCIS - Oncology Nurse Advisor
Tamoxifen and Breast Cancer (Yale Fastback Series): DeGregorio, Michael W., Wiebe, Valerie J.: 9780300079517: Amazon.com: Books
5 tips for scientific survival from the Father of Tamoxifen
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial - The Lancet
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial - The Lancet
Combining Tamoxifen with Antidepressants: What You Need to Know
